AHR and obesity due to melanocortin 4 receptor deficiency: Similarly, it has been reported that obese mice subjected to a diet containing the AhR antagonist α-NF, had a significant loss of body mass, reduced PPAR-α activity, and reversed the fatty liver disease and expression of obesity markers, such as stearoyl-CoA desaturase 1 and phosphoprotein 1 [117].